AbCellera Biologics Inc.

ABCL | NASDAQ

Price Alert Chart Builder DCF Calculator

$12.84

+$0.18 (+1.42%)

Sep 22, 2026, 10:48 AM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Income Statement Balance Sheet Cashflow Statement Ratios

Annual Quarterly TTM

Fiscal Year Period Ending	FY 2025 Dec 30, 2025	FY 2024 Dec 30, 2024	FY 2023 Dec 30, 2023	FY 2022 Dec 30, 2022	FY 2021 Dec 30, 2021	FY 2020 Dec 30, 2020
Net Income	-146.41M	-162.86M	-146.4M	158.52M	153.46M	118.92M
Depreciation & Amortization	22.17M	97M	30.89M	33.1M	17.25M	5.27M
Stock-Based Compensation	55.79M	67.58M	64.18M	49.48M	30.65M	8.4M
Other Working Capital	-18.53M	38.64M	56.01M	51.47M	17.79M	79.72M
Other Non-Cash Items	7.85M	-84.44M	-7.74M	8.55M	3.57M	4.71M
Deferred Income Tax	n/a	n/a	1.96M	-2.11M	-2.02M	2.1M
Change in Working Capital	-70.69M	-25.84M	13.23M	29.83M	41.67M	-116.7M
Operating Cash Flow	-131.3M	-108.56M	-43.88M	277.36M	244.58M	22.69M
Capital Expenditures	-42.77M	-78.4M	-77.51M	-72.66M	-58.45M	-14.67M
Cash Acquisitions	-7.14M	-19.63M	-13.69M	-25.68M	-11.46M	-106.89M
Purchase of Investments	-453.14M	-765.09M	-1.07B	-781.35M	-322.57M	n/a
Sales Maturities Of Investments	506.07M	948.81M	910.94M	510.63M	27.61M	n/a
Other Investing Acitivies	84.72M	35.71M	25.31M	16.43M	32.62M	-3.22M
Investing Cash Flow	87.75M	121.41M	-221.11M	-352.63M	-332.25M	-119.78M
Debt Repayment	n/a	13.5M	11.59M	2.76M	-951K	85.15M
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	14.08M	-729K	-1.23M	-4.38M	-7.55M	1M
Financial Cash Flow	14.08M	12.77M	10.36M	-1.63M	-3.89M	683.65M
Net Cash Flow	-28.37M	23.01M	-254.04M	-86.49M	-92.97M	586.56M
Free Cash Flow	-174.07M	-186.95M	-121.38M	204.7M	186.13M	8.02M
Adj. Free Cash Flow	-229.86M	-254.53M	-185.57M	155.22M	155.49M	-380K
Maintenance CapEx	n/a	-78.4M	-77.51M	-36.89M	-25.84M	n/a
Growth CapEx	-42.77M	n/a	n/a	-35.77M	-32.61M	-14.67M
Owner Earnings	-131.3M	-186.95M	-121.38M	240.47M	218.74M	22.69M